Cargando…
Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis
Background: There is growing evidence of the role of inflammation in Amyotrophic Lateral Sclerosis (ALS) during the last decade. Although the origin of ALS remains unknown, multiple potential inflammatory biomarkers have been described in ALS patients and murine models of this disease to explain the...
Autores principales: | Moreno-Martínez, Laura, de la Torre, Miriam, Toivonen, Janne M., Zaragoza, Pilar, García-Redondo, Alberto, Calvo, Ana Cristina, Osta, Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473074/ https://www.ncbi.nlm.nih.gov/pubmed/31031774 http://dx.doi.org/10.3389/fimmu.2019.00801 |
Ejemplares similares
-
MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis
por: Toivonen, Janne M., et al.
Publicado: (2014) -
Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
por: Moreno-Martinez, Laura, et al.
Publicado: (2019) -
Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis
por: Calvo, Ana Cristina, et al.
Publicado: (2022) -
Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
por: Calvo, Ana C., et al.
Publicado: (2014) -
Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis
por: Gasco, Samanta, et al.
Publicado: (2017)